www.pharmaceutical-technology.com
News, views and contacts from the global Pharmaceutical industry
25 May 2017
WEEKLY UPDATE
Digital Magazine
Latest Companies

Quality Assurance Management (QAM) - Inspection and Analytical Services for the Pharmaceutical Industry

Medicon Valley Inhalation Consortium (MVIC) - Full Service CRO and Inhalation Product Development Specialists

ILC Dover - Flexible Powder Containment Technologies

Ce3 - Contract Research Organisation for Early Development of First-in-Human Oncology Clinical Trials

PAIRimmune - Preclinical Immunology for Vaccine and Immunotherapy Development

Pharmaceutical Technology on Facebook

Join Pharmaceutical Technology on Facebook!
We're on Facebook and we'd like you to join us there too. Now there's a new way to keep up on our biggest stories, breaking news and exclusive content. Become a fan of Pharmaceutical Technology on Facebook and click the 'like' button. Simple as that!

Press Releases

Upcoming Quality Assurance and Regulatory Adherence Courses by NSF
NSF International has released a list of upcoming courses for June and July.

What is a Biosimilar and How Does it Differ Compared to Drug Development?
Prior to 23 March 2010, there was no regulatory pathway for biosimilar development in the US.

BLUE Software Celebrates 20th Anniversary
To celebrate its 20th anniversary, BLUE Software has announced it will introduce new software as a service (SaaS) products BLUE Essentials, BLUE Premier, and BLUE Enterprise to its label and artwork management (LAM) technology.

Prudential Cleanroom Services Completes Surveillance Audits
Prudential Cleanroom Services has announced that it has completed its surveillance audits for ISO 9001:2008 through TÜV SÜD America.

NSF International to Attend 2nd PDA Europe Annual Meeting, Germany
NSF International's pharma biotech team has announced it will be present at the 2nd PDA Europe Annual Meeting in Berlin.

White Papers

Flexible Drug Containers for Parenteral Drugs
Self-medication is becoming more popular, driven by cost considerations. Valuable time of healthcare personnel and the high cost of hospital stays are outweighing the costs of treatment...

Rules for Investigating Good Manufacturing Practice (GMP) Deviations in Sterile Processing
When things go wrong, there are five non-negotiable processes that should be defined on your deviation investigation standards of practice (SOP): immediate engagement, gemba, triaging using...

Guide to Pharmaceutical Labelling Excellence
BLUE has created the articles and tools in this guide to help you focus on key activities essential for energising transformation in your organisation....

Autoclaves, Sterilisers, and Thermal Equipment for the Laboratory, Research, and Medical Industry
LTE Scientific's new Touchclave EcoTech autoclave combined a high level of standard features with exceptionally low energy and water...

Solving Complex Pharmaceuticals Dosing Tasks
For dosing and filling in the pharmaceutical industry, you usually think of water-like, non-viscous products such as solutions for...

Features

Bluerock: Canada’s stem cell contender on the journey from petri dish to clinical trial
Toronto-based regenerative medicine biotech BlueRock Therapeutics was launched in December with a massive $225m series A financing. So what stem cell-based therapies is the company working on?

Micro-machines: nanotech offers new possibilities for disease detection and drug delivery
For the first time, miniscule molecular machines designed for early disease detection and targeted drug delivery have been shown to work in living cells. Elly Earls meets the researchers behind the breakthrough to find out more.

Pharma Technology Focus – Issue 59
In this issue: Challenging the link between innovation and US drug pricing, the impact of Brexit on life sciences companies, a new study on the effects of cognitive-enhancing drugs, using crowdfunding to unlock cancer therapies, and more.

Challenging the link between pharma innovation and US drug pricing
A new study claims to debunk the well-worn connection between inflated US drug prices and big pharma’s R&D spending. But what is the connection between innovation and pricing in the pharma space, and is it the whole story?

Brain boosters: exploring the grey area of off-label ‘smart drugs’
The growing trend for the unlicensed use of cognitive-enhancing drugs to improve performance is prompting calls for more research into the field. Has the era of brain-boosting ‘smart pills’ arrived, and what do we still need to find out about the safety and efficacy of drugs like modafinil and methylphenidate in healthy adults?

Projects

European Molecular Biology Laboratory Site, Barcelona
European Molecular Biology Laboratory (EMBL) is developing a new facility within the Barcelona Biomedical Research Park (PRBB) campus in Spain.

AstraZeneca R&D Centre and Corporate Headquarters, Cambridge
UK-Swedish pharmaceutical and biologics company AstraZeneca is building a new global R&D centre and corporate headquarters on the Cambridge Biomedical Campus (CBC) in Cambridge, UK.

Medical Sciences Building (MSB) II, Texas Tech University Health Sciences Center El Paso
Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) will soon feature a new medical sciences building at its campus in Texas, US.

UTEP Interdisciplinary Research Building (IDRB), Texas
The University of Texas at El Paso (UTEP) has initiated construction of an interdisciplinary research building (IDRB) at 500 West University Avenue in Texas, US.

Biosciences Partnership Building, Phoenix
The University of Arizona (UA) College of Medicine in Phoenix, Arizona, US, broke ground on a new research facility named Biosciences Partnership Building on the Phoenix Biomedical Campus, a major bioresearch and education hub in downtown Phoenix in October 2014.

Follow Us:   Facebook Facebook    Twitter Twitter   
Click here to unsubscribe from the newsletter | Privacy Policy
You are receiving this email because you are either a valued subscriber to Pharmaceutical Technology or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties.

www.pharmaceutical-technology.com is a product of Kable. Copyright 2017 Kable, a trading division of Kable Intelligence Limited.